食管鳞状细胞癌患者同步放化疗期间经皮内镜下胃造瘘的影响:一项前瞻性研究
这项前瞻性研究纳入141例食管鳞状细胞癌患者,比较口服进食、经皮内镜下胃造瘘(PEG)和鼻胃管(NGT)三种肠内营养途径在同步放化疗(CCRT)期间对营养状态和不良事件的影响。结果显示PEG能有效维持体重和骨骼肌指数,提高同步化疗完成率,并减少至少2级放射性食管炎的发生。
要点
- PEG组同步化疗完成率最高,且能有效维持体重和骨骼肌指数。
- 多因素分析显示计划靶体积、口服进食和NGT喂养途径与至少2级放射性食管炎相关。
- 口服进食组基线营养状态显著优于PEG组和NGT组,但CCRT期间体重和骨骼肌指数下降最显著。
核心结论
- PEG能有效维持食管癌患者CCRT期间的体重和骨骼肌指数。
- PEG提高了同步化疗完成率并减少了至少2级放射性食管炎的发生。
研究设计与样本
- 前瞻性研究,共纳入141例食管鳞状细胞癌患者,其中口服进食组38例、PEG组74例、NGT组29例。
- 评估CCRT前后的患者生成主观全面评估评分、骨骼肌指数和生活质量,并记录PEG和NGT喂养期间不良事件的发生率。
- 分析不同营养途径与CCRT相关不良事件(如放射性食管炎和骨髓抑制)的相关性。
主要发现
- 基线时口服进食组营养状态显著优于PEG组和NGT组,且疾病分期更低。
- CCRT期间口服进食组体重和骨骼肌指数下降最显著。
- 同步化疗完成率在PEG组最高。
- 多因素分析显示计划靶体积、口服进食和NGT喂养途径与至少2级放射性食管炎相关。
临床怎么用
- 作者认为PEG可有效维持食管癌患者CCRT期间的体重和骨骼肌指数,并提高同步化疗完成率、减少至少2级放射性食管炎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: This prospective study aimed to compare the changes in nutritional status and adverse events among patients with esophageal squamous cell carcinoma who received enteral nutrition through oral intake, PEG, and an enteral nasogastric tube (NGT) during concurrent chemoradiotherapy (CCRT). METHODS: Of 141 included patients, 38, 74, and 29 patients were fed through oral intake, PEG, and NGTs, respectively. The clinical characteristics and baseline nutritional status of the 3 groups were recorded and analyzed. The Patient-Generated Subjective Global Assessment score, skeletal muscle index, and quality of life were evaluated before and after CCRT; the incidence of adverse events during feeding using PEG and NGTs was also recorded. The correlations among the different nutritional pathways and the CCRT-related adverse events (eg, radiation esophagitis and myelosuppression) were assessed. RESULTS: At baseline, the oral intake group had a significantly better nutritional status and lower disease stage than those in the PEG and NGT groups. However, during CCRT, the oral intake group exhibited the most significant decreases in weight and skeletal muscle index. The synchronous chemotherapy completion rate was the highest in the PEG group. Multivariate analysis showed that the planning tumor volume and oral intake and NGT feeding pathways were associated with radiation esophagitis of at least grade 2. CONCLUSIONS: We found that PEG effectively maintained the body weight and skeletal muscle index of patients with esophageal cancer during CCRT. PEG also improved the synchronous chemotherapy completion rate and reduced the occurrence of at least grade 2 radiation esophagitis. (Clinical trial registration number: NCT04199832.).
引用
- Dong J, Dai Z, Cao F, et al. Effects of PEG in patients with esophageal squamous cell carcinoma during concurrent chemoradiotherapy: a prospective study. Gastrointest Endosc. 2023. PMID: 37150411. doi:10.1016/j.gie.2023.04.2094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。